✦ LIBER ✦

After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?

✍ Scribed by Zili Zhang; David J. Hinrichs; Huiying Lu; Hong Chen; Wenwei Zhong; Jay K. Kolls

Book ID: 116576092
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 420 KB
Volume: 7
Category: Article
ISSN: 1567-5769
DOI: 10.1016/j.intimp.2006.09.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting the p40 cytokines interleukin

Targeting the p40 cytokines interleukin (IL)-12 and IL-23 in Crohn's disease

✍ Geertruida M. Veldman 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Interleukin (IL)-23 Suppresses IL-10 in

Interleukin (IL)-23 Suppresses IL-10 in Inflammatory Bowel Disease

✍ Liu, Z.; Feng, B.-S.; Yang, S.-B.; Chen, X.; Su, J.; Yang, P.-C. 📂 Article 📅 2011 🏛 The American Society for Biochemistry and Molecula 🌐 English ⚖ 834 KB

M2076 Genetic Variants L290P and R381Q o

M2076 Genetic Variants L290P and R381Q of the Interleukin-23 Receptor (IL23R) Gene Are Associated with Inflammatory Bowel Disease (IBD) in a Familial and Sporadic IBD

✍ Lin, Zhenwu; Poritz, Lisa S.; Li, Tong-Yi; Byrnes, Kathryn; Wang, Yunhua; Gebhar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB